All In Biotech

Free tool

FAERS Monitor: Plegridy

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125499 or its brand name (Plegridy, Peginterferon Beta-1a). Reports on generic versions are filed under their own applications.

Reports

13,098

Serious

5,630

43% of reports

Hospitalization

3,151

Death reported

336

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • influenza like illness1,470
  • injection site erythema1,065
  • multiple sclerosis relapse979
  • fatigue715
  • headache619
  • pain609
  • injection site reaction580
  • device malfunction572
  • multiple sclerosis566
  • pyrexia522
  • memory impairment474
  • malaise471
  • drug delivery system malfunction468
  • injection site pain451
  • fall439

Reports by year received

View as table
YearReports
20131
201418
2015646
20162,699
20171,997
20181,831
20191,326
20201,077
2021919
2022808
2023610
2024463
2025465
2026238

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,041,061 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug delivery system malfunctionSignal468161.7147.367,783
influenza like illnessSignal1,47029.227.839,424
multiple sclerosis relapseSignal97923.321.920,599
multiple sclerosisSignal56619.217.79,666
injection site erythemaSignal1,06513.913.112,700
injection site reactionSignal58013.612.66,747
device malfunctionSignal57213.212.26,390
memory impairmentSignal4745.65.11,772
pyrexiaSignal5222.42.2442
injection site painSignal4512.42.2358
fallSignal4392.11.9262
malaise4711.71.6146
pain6091.61.5138
headache6191.61.5137
fatigue7151.51.4113

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.